What sector does MT GENEX CORPORATION belong to?

MT GENEX CORPORATION operates in the Real Estate sector, specifically the Real Estate industry, and is listed on the US markets.

What is the current share price of 9820?

As of the latest available quote, 9820 traded at ¥3,725.00. This price is delayed and cached for about 15 minutes.

What is the P/E ratio of 9820?

MT GENEX CORPORATION has a price-to-earnings (P/E) ratio of about 12.74. The P/E ratio compares the share price to earnings per share and is most useful when compared with sector peers and the company's own history.

What is the market capitalisation of 9820?

The market capitalisation of MT GENEX CORPORATION is approximately ¥4.01B.

Is MT GENEX CORPORATION profitable?

For its latest reported financial year, MT GENEX CORPORATION recorded a net profit margin of about 6.68%.

Does 9820 pay a dividend?

MT GENEX CORPORATION currently has a dividend yield of about 1.07%.

What is the return on equity (ROE) of 9820?

MT GENEX CORPORATION has a return on equity (ROE) of about 7.40%. ROE measures how much profit a company generates relative to shareholders' equity.

What is the 52-week high and low of 9820?

Over the past 52 weeks, 9820 has traded between a low of ¥3,210.00 and a high of ¥4,290.00.

MT GENEX CORPORATION

9820 TSE Real Estate Real Estate

TSE Standard

¥3,725.00

+0.00%

Delayed · cached 15 min

Fair value analysis

9820

MT GENEX CORPORATION

¥3,725.00

Close used for this calculation

¥3,746.96Fair value

Financial DNA Score

Profitability · Returns · Balance Sheet · Efficiency · Growth

65/100

Profitability15/25

Returns11/25

Balance Sheet23/25

Efficiency16/25

Growth11/25

Strong

Quality radar

Consensus fair value

¥3,746.96

Near FV

▲ +0.6% against the close used

Model range ¥985.55 – ¥6,794.32

The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.

Price target range & 52-week position

Bear¥985.55Fair value¥3,746.96Bull¥6,794.32

FairClose

52-week traded range

52W low ¥3,210.0052W high ¥4,140.00

The 52-week range is measured from the stored price history, not estimated.

Valuation summary

Trading close to the consensus fair value

MT GENEX CORPORATION closed at ¥3,725.00, 0.6% below the consensus fair value of ¥3,746.96 drawn from 9 valuation models.

Financial DNA score 65/100 — Strong. P/E of 12.7x against the 20x sector multiple the P/E model uses.

Quantitative summary only — not investment advice.

All valuation models

DCF Valuation

¥985.55

-73.5%

Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10

g=9%, r=10%, tg=3%, n=10yr

Graham Number

¥5,190.70

+39.3%

√(22.5 × EPS × BVPS)

EPS=292.54, BVPS=4093.41

P/E Fair Value

¥5,850.80

+57.1%

EPS × 20x (sector P/E)

EPS=292.54, Sector P/E=20x

Peter Lynch (PEG)

¥3,016.09

-19.0%

EPS × Growth% (PEG = 1 is fair)

EPS=292.54, g=10.3%

EV/EBITDA

¥6,794.32

+82.4%

(EBITDA × 15.2x − Net Debt) ÷ Shares

EBITDA=487.6M

Dividend Discount (DDM)

¥2,152.31

-42.2%

D1 ÷ (r − g) where D1 = D0×(1+g)

D0=39.86, r=10%, g=8%

Book Value (P/B)

¥1,432.69

-61.5%

BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]

BVPS=4093.41, ROE=7.4%, g=6%, r=10%

Reverse DCF

¥3,725.00

+0.0%

Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV

Implied: 1% | Historical: 10.3%

Margin of Safety

¥3,006.76

-19.3%

Avg(DCF, Graham, P/E) × 75% (25% safety buffer)

Avg fair value=4009.02, MoS=25%

Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.

Educational data only. Not a recommendation to buy, sell or hold any security.

Fair value analysis

Consensus fair value

Price target range & 52-week position

Valuation summary

All valuation models

Equity Timer